Ocular Therapeutix, Inc.
OCUL
$11.92
$0.342.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.23% | -65.60% | -6,972.29% | -111.67% | -113.89% |
| Total Depreciation and Amortization | 6.63% | -0.73% | 7.75% | 46.63% | 90.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.10% | -42.16% | 101.30% | 228.31% | 248.23% |
| Change in Net Operating Assets | 142.52% | 113.09% | -119.46% | 168.34% | -420.28% |
| Cash from Operations | -31.82% | -75.60% | -372.83% | -23.55% | -69.66% |
| Capital Expenditure | -658.04% | 55.99% | 65.64% | 62.71% | 92.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -658.04% | 55.99% | 65.64% | 62.71% | 92.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.70% | -95.83% | 442.60% | -77.23% | 411,724.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.70% | -95.83% | -91.96% | -77.23% | 411,724.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.78% | -141.19% | -173.89% | -87.99% | 1,333.48% |